REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pure Biologics S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Other Basic Organic Chemical Manufacturing | Pharmaceutical Preparation Manufacturing | Adhesive Manufacturing | Explosives Manufacturing | All Other Chemical Product and Preparation Manufacturing | Pharmacies and Drug Stores | Department Stores | Scientific Research and Development Services | All Other Professional, Scientific, and Technical Services
Full name: Pure Biologics S.A. Profile Updated: March 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Pure Biologics develops unique therapeutic formats, including afucosylated fully human anti-GARP antibody, PBA-0111, for immuno-oncology projects. The company focuses on capturing valuable pharmacodynamic data directly in patients at an early clinical stage to reduce the risk of failure of later clinical trials.

Headquarters
ul. Szczytnicka 11
Wroclaw; Dolnoslaskie; Postal Code: 50-382

Contact Details: Purchase the Pure Biologics S.A. report to view the information.

Website: http://www.purebiologics.pl

Basic Information
Total Employees:
Purchase the Pure Biologics S.A. report to view the information.
Outstanding Shares:
Purchase the Pure Biologics S.A. report to view the information.
Registered Capital:
Purchase the Pure Biologics S.A. report to view the information.
Financial Auditors:
Purchase the Pure Biologics S.A. report to view the information.
Incorporation Date:
January 10, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
16.42%
Subsidiaries
Bio Animali Sp. z o.o.
15%
Company Performance
Financial values in the chart are available after Pure Biologics S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
81.2%▲
Total operating revenue
81.2%▲
Operating Profit/Loss (EBIT)
33.53%▲
EBITDA
33.44%▲
Net Profit/Loss for the Period
-48.71%▼
Total Assets
-87.67%▼
Total Equity
-289.69%▼
Operating Profit Margin (ROS)
344.44%▲
Net Profit Margin
58.59%▲
Return on Equity (ROE)
-10.15%▼
Debt/Equity
199.18%▲
Quick Ratio
-0.61%▼
Cash Ratio
-0.07%▼

Similar companies

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy
 
Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy
Pit-Radwar S.A.
 
Naukowa I Akademicka Siec Komputerowa - Panstwowy Instytut Badawczy
"Novo Nordisk Pharma" Sp. z o.o.
 
Siec Badawcza Lukasiewicz-Instytut Lotnictwa
Care Clinic Sp. z o.o.
 
Bioresearch Group Sp. z o.o.
Gispro Technologies Sp. z o.o.
 
Qsar Lab Sp. z o.o.
Iclab Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo